ORC4L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.052000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.013400E-01
Normal-vs-Stage2
7.355000E-01
Normal-vs-Stage3
2.508800E-01
Normal-vs-Stage4
6.169000E-01
Stage1-vs-Stage2
8.507000E-01
Stage1-vs-Stage3
1.800570E-01
Stage1-vs-Stage4
7.941600E-01
Stage2-vs-Stage3
1.564440E-01
Stage2-vs-Stage4
9.281000E-01
Stage3-vs-Stage4
1.477230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.222600E-01
Normal-vs-AfricanAmerican
5.471200E-01
Normal-vs-Asian
7.489400E-01
Caucasian-vs-AfricanAmerican
4.411600E-01
Caucasian-vs-Asian
7.106000E-01
AfricanAmerican-vs-Asian
8.654000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.759800E-01
Normal-vs-Female
8.369400E-01
Male-vs-Female
7.188000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.069800E-01
Normal-vs-Age(41-60Yrs)
4.633400E-01
Normal-vs-Age(61-80Yrs)
9.918200E-01
Normal-vs-Age(81-100Yrs)
9.963400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.468200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.161600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.230400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.301400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.577030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.890600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.507200E-01
Normal-vs-Daily Drinker
8.797600E-01
Normal-vs-Weekly Drinker
8.262600E-01
Normal-vs-Occasional Drinker
3.827000E-01
Normal-vs-Social Drinker
7.087600E-01
Non Drinker-vs-Daily Drinker
8.325800E-01
Non Drinker-vs-Weekly Drinker
7.663400E-01
Non Drinker-vs-Occasional Drinker
3.303600E-02
Non Drinker-vs-Social Drinker
4.700600E-01
Daily Drinker-vs-Weekly Drinker
9.244200E-01
Daily Drinker-vs-Occasional Drinker
4.114500E-02
Daily Drinker-vs-Social Drinker
4.005200E-01
Weekly Drinker-vs-Occasional Drinker
5.795600E-02
Weekly Drinker-vs-Social Drinker
3.756600E-01
Occasional Drinker-vs-Social Drinker
1.155230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.614060E-02
Normal-vs-Grade 2
5.515800E-03
Normal-vs-Grade 3
3.389000E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.038300E-02
Grade 1-vs-Grade 3
3.679300E-03
Grade 1-vs-Grade 4
1.614060E-02
Grade 2-vs-Grade 3
6.094000E-01
Grade 2-vs-Grade 4
5.515800E-03
Grade 3-vs-Grade 4
3.389000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.486800E-01
Normal-vs-NonDiabetic
7.572400E-01
Diabetic-vs-NonDiabetic
6.742100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.998800E-01
Normal-vs-NoPancreatitis
8.609000E-01
Pancreatitis-vs-NoPancreatitis
7.219400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.353000E-01
Normal-vs-N1
7.092200E-01
N0-vs-N1
5.783600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.357200E-01
Normal-vs-TP53-NonMutant
8.407400E-01
TP53-Mutant-vs-TP53-NonMutant
3.383100E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
